How much profit has Compugen made this year?
Compugen has made -14.61 M USD this year.
Compugen Net Income 2024
Compugen Net Income
-14.61 M USD
Ticker
CGEN
ISIN
IL0010852080
WKN
553001
In 2024, Compugen's profit amounted to -14.61 M USD, a -22.08% increase from the -18.75 M USD profit recorded in the previous year.
The Compugen Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2029e | - |
| 2028e | - |
| 2027e | - |
| 2026e | - |
| 2025e | - |
| 2024e | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
| 2015 | - |
| 2014 | - |
| 2013 | - |
| 2012 | - |
| 2011 | - |
| 2010 | - |
| 2009 | - |
| 2008 | - |
| 2007 | - |
| 2006 | - |
| 2005 | - |
| 2004 | - |
Compugen Revenue, EBIT, Net Income IL0010852080 · 553001
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Compugen, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Compugen from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Compugen’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Compugen. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Compugen’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Compugen’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Compugen’s growth potential.
Compugen Revenue, EBIT and net profit per share
| Date | Compugen Revenue | Compugen EBIT | Compugen Net Income |
|---|---|---|---|
| 2029e | 53.43 M undefined | -42.73 M undefined | -60.28 M undefined |
| 2028e | 60.52 M undefined | -26.32 M undefined | -18.27 M undefined |
| 2027e | 58.8 M undefined | -18.41 M undefined | 0 undefined |
| 2026e | 48.32 M undefined | -8.36 M undefined | -5.48 M undefined |
| 2025e | 41.18 M undefined | -9.08 M undefined | -5.94 M undefined |
| 2024e | 52.62 M undefined | 5.77 M undefined | -14.61 M undefined |
| 2023 | 33.46 M undefined | -12.99 M undefined | -18.75 M undefined |
| 2022 | 7.5 M undefined | -35.37 M undefined | -33.69 M undefined |
| 2021 | 6 M undefined | -35.07 M undefined | -34.2 M undefined |
| 2020 | 2 M undefined | -31.5 M undefined | -29.7 M undefined |
| 2019 | 0 undefined | -28.88 M undefined | -27.34 M undefined |
| 2018 | 17.8 M undefined | -23.23 M undefined | -22.6 M undefined |
| 2017 | 0 undefined | -37.41 M undefined | -37.07 M undefined |
| 2016 | 710,000 undefined | -32.58 M undefined | -31.51 M undefined |
| 2015 | 9.28 M undefined | -20.92 M undefined | -20.16 M undefined |
| 2014 | 12.37 M undefined | -12.34 M undefined | -11.09 M undefined |
| 2013 | 3.55 M undefined | -17.04 M undefined | -14.08 M undefined |
| 2012 | 240,000 undefined | -13.54 M undefined | -13.63 M undefined |
| 2011 | 0 undefined | -11.98 M undefined | -12 M undefined |
| 2010 | 1.12 M undefined | -7.88 M undefined | -7.2 M undefined |
| 2009 | 250,000 undefined | -7.63 M undefined | -3.83 M undefined |
| 2008 | 340,000 undefined | -12.91 M undefined | -12.53 M undefined |
| 2007 | 180,000 undefined | -12.46 M undefined | -12.11 M undefined |
| 2006 | 220,000 undefined | -13 M undefined | -13.02 M undefined |
| 2005 | 650,000 undefined | -13.73 M undefined | -13.98 M undefined |
| 2004 | 2.63 M undefined | -15.58 M undefined | -13.72 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 2.63 M USD | -15.58 M USD | -13.72 M USD |
| 2005 | 650,000 USD | -13.73 M USD | -13.98 M USD |
| 2006 | 220,000 USD | -13 M USD | -13.02 M USD |
| 2007 | 180,000 USD | -12.46 M USD | -12.11 M USD |
| 2008 | 340,000 USD | -12.91 M USD | -12.53 M USD |
| 2009 | 250,000 USD | -7.63 M USD | -3.83 M USD |
| 2010 | 1.12 M USD | -7.88 M USD | -7.2 M USD |
| 2011 | 0 USD | -11.98 M USD | -12 M USD |
| 2012 | 240,000 USD | -13.54 M USD | -13.63 M USD |
| 2013 | 3.55 M USD | -17.04 M USD | -14.08 M USD |
| 2014 | 12.37 M USD | -12.34 M USD | -11.09 M USD |
| 2015 | 9.28 M USD | -20.92 M USD | -20.16 M USD |
| 2016 | 710,000 USD | -32.58 M USD | -31.51 M USD |
| 2017 | 0 USD | -37.41 M USD | -37.07 M USD |
| 2018 | 17.8 M USD | -23.23 M USD | -22.6 M USD |
| 2019 | 0 USD | -28.88 M USD | -27.34 M USD |
| 2020 | 2 M USD | -31.5 M USD | -29.7 M USD |
| 2021 | 6 M USD | -35.07 M USD | -34.2 M USD |
| 2022 | 7.5 M USD | -35.37 M USD | -33.69 M USD |
| 2023 | 33.46 M USD | -12.99 M USD | -18.75 M USD |
| 2024e | 52.62 M USD | 5.77 M USD | -14.61 M USD |
| 2025e | 41.18 M USD | -9.08 M USD | -5.94 M USD |
| 2026e | 48.32 M USD | -8.36 M USD | -5.48 M USD |
| 2027e | 58.8 M USD | -18.41 M USD | 0 USD |
| 2028e | 60.52 M USD | -26.32 M USD | -18.27 M USD |
| 2029e | 53.43 M USD | -42.73 M USD | -60.28 M USD |
Compugen stock margins IL0010852080 · 553001
The Compugen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Compugen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Compugen.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Compugen's sales revenue. A higher gross margin percentage indicates that the Compugen retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Compugen's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Compugen's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Compugen's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Compugen. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Compugen's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Compugen Margin History
| Compugen Gross margin | Compugen Profit margin | Compugen EBIT margin | Compugen Profit margin |
|---|---|---|---|
| 2029e | 94.01 % | -79.98 % | -112.82 % |
| 2028e | 94.01 % | -43.49 % | -30.18 % |
| 2027e | 94.01 % | -31.31 % | 0 % |
| 2026e | 94.01 % | -17.3 % | -11.34 % |
| 2025e | 94.01 % | -22.04 % | -14.41 % |
| 2024e | 94.01 % | 10.96 % | -27.77 % |
| 2023 | 94.01 % | -38.83 % | -56.05 % |
| 2022 | 87.07 % | -471.6 % | -449.2 % |
| 2021 | 88.67 % | -584.5 % | -570 % |
| 2020 | 97 % | -1,575 % | -1,485 % |
| 2019 | 94.01 % | 0 % | 0 % |
| 2018 | 94.21 % | -130.51 % | -126.97 % |
| 2017 | 94.01 % | 0 % | 0 % |
| 2016 | 69.01 % | -4,588.73 % | -4,438.03 % |
| 2015 | 82.33 % | -225.43 % | -217.24 % |
| 2014 | 72.92 % | -99.76 % | -89.65 % |
| 2013 | 29.3 % | -480 % | -396.62 % |
| 2012 | 16.67 % | -5,641.67 % | -5,679.17 % |
| 2011 | 94.01 % | 0 % | 0 % |
| 2010 | 79.46 % | -703.57 % | -642.86 % |
| 2009 | 100 % | -3,052 % | -1,532 % |
| 2008 | 97.06 % | -3,797.06 % | -3,685.29 % |
| 2007 | 100 % | -6,922.22 % | -6,727.78 % |
| 2006 | 95.45 % | -5,909.09 % | -5,918.18 % |
| 2005 | 76.92 % | -2,112.31 % | -2,150.77 % |
| 2004 | 58.17 % | -592.4 % | -521.67 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 58.17 % | -592.4 % | -521.67 % |
| 2005 | 76.92 % | -2,112.31 % | -2,150.77 % |
| 2006 | 95.45 % | -5,909.09 % | -5,918.18 % |
| 2007 | 100 % | -6,922.22 % | -6,727.78 % |
| 2008 | 97.06 % | -3,797.06 % | -3,685.29 % |
| 2009 | 100 % | -3,052 % | -1,532 % |
| 2010 | 79.46 % | -703.57 % | -642.86 % |
| 2011 | 94.01 % | 0 % | 0 % |
| 2012 | 16.67 % | -5,641.67 % | -5,679.17 % |
| 2013 | 29.3 % | -480 % | -396.62 % |
| 2014 | 72.92 % | -99.76 % | -89.65 % |
| 2015 | 82.33 % | -225.43 % | -217.24 % |
| 2016 | 69.01 % | -4,588.73 % | -4,438.03 % |
| 2017 | 94.01 % | 0 % | 0 % |
| 2018 | 94.21 % | -130.51 % | -126.97 % |
| 2019 | 94.01 % | 0 % | 0 % |
| 2020 | 97 % | -1,575 % | -1,485 % |
| 2021 | 88.67 % | -584.5 % | -570 % |
| 2022 | 87.07 % | -471.6 % | -449.2 % |
| 2023 | 94.01 % | -38.83 % | -56.05 % |
| 2024e | 94.01 % | 10.96 % | -27.77 % |
| 2025e | 94.01 % | -22.04 % | -14.41 % |
| 2026e | 94.01 % | -17.3 % | -11.34 % |
| 2027e | 94.01 % | -31.31 % | 0 % |
| 2028e | 94.01 % | -43.49 % | -30.18 % |
| 2029e | 94.01 % | -79.98 % | -112.82 % |
Compugen Aktienanalyse
What does Compugen do?
Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Compugen's Profit Margins
The profit margins of Compugen represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Compugen's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Compugen's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Compugen's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Compugen’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Compugen stock
How has the profit developed compared to last year?
The profit has increased by -22.08% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Compugen publish its earnings?
Compugen publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Compugen?
The profits of Compugen are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Compugen?
You can learn more about the earnings of Compugen by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Compugen pay?
Over the past 12 months, Compugen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Compugen is expected to pay a dividend of 0 USD.
What is the dividend yield of Compugen?
The current dividend yield of Compugen is .
When does Compugen pay dividends?
Compugen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Compugen?
Compugen paid dividends every year for the past 0 years.
What is the dividend of Compugen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Compugen located?
Compugen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Compugen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Compugen from 12/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/30/2024.
When did Compugen pay the last dividend?
The last dividend was paid out on 12/30/2024.
What was the dividend of Compugen in the year 2023?
In the year 2023, Compugen distributed 0 USD as dividends.
In which currency does Compugen pay out the dividend?
The dividends of Compugen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Compugen
Our stock analysis for Compugen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Compugen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
